|1.||Uchida, N: 1 article (12/2000)|
|2.||Nogusa, H: 1 article (12/2000)|
|3.||Maekawa, R: 1 article (12/2000)|
|4.||Yoshioka, T: 1 article (12/2000)|
|5.||Hamana, H: 1 article (12/2000)|
12/01/2000 - "Complete tumor regression followed by long-term tumor-free survival was frequently observed when CMPul-FG-DXR was administered i.v. three times at a dose equivalent to 10 mg / kg of DXR. "
12/01/2000 - "CMPul-FG-DXR may be useful as a cancer chemotherapy agent against solid tumors and metastases."
12/01/2000 - "The antitumor efficacy of the conjugate of doxorubicin (DXR) and carboxymethylpullulan (CMPul) with Phe-Gly spacer (CMPul-FG-DXR) was evaluated using murine tumor models and compared with that of DXR. "
|2.||Neoplasm Metastasis (Metastasis)
|3.||Non-Hodgkin Lymphoma (Lymphosarcoma)
|4.||Body Weight (Weight, Body)
|1.||Drug Therapy (Chemotherapy)